skip to main content

CentraState Medical Center Launches Emergency Angioplasty Program: Life Saving Procedure for Heart Attack Patients

CentraState Medical Center Launches Emergency Angioplasty Program: Life Saving Procedure for Heart Attack Patients

By |2023-07-05T16:33:09-04:00November 21st, 2022|

CentraState Medical Center received approval from the New Jersey Department of Health to perform emergency angioplasty, also known as emergency PCI (percutaneous coronary intervention). The hospital’s interventional cardiologists have already begun using the life-saving emergency procedure for area heart attack victims.

“The ability for us to perform emergency PCI locally in Freehold significantly improves time to treatment allowing patients who show signs of a heart attack to get immediate care in CentraState’s catheterization laboratory, rather than transferring to another hospital,” said Jatinchandra Patel, DO, medical director of the Cardiovascular Interventional Laboratory. “Research has proven that patients have the best chance of recovery if their arteries are opened within 90 minutes after a heart attack.”

Emergency angioplasty allows physicians to preserve heart muscle by quickly restoring normal blood flow with a minimally invasive procedure. In this procedure, a thin, flexible catheter is inserted through the wrist or groin and threaded through the arteries of the heart. A balloon is inflated to open the blocked arteries of the heart, and in the majority of cases, stents are inserted. The state-of-the-art, lifesaving treatment is available 24 hours a day.

CentraState, with its team of experienced cardiologists, has been performing cardiac catheterizations since 2005 with excellent outcomes and patient satisfaction. The approval to provide emergency angioplasty builds on the medical center’s accreditation as a Chest Pain Center. Together with the hospital’s emergency department staff, CentraState’s experienced physicians and cardiac catheterization lab team are able to improve a heart attack patient’s chances for recovery substantially by performing emergency angioplasty.

“This is a major milestone for CentraState, but more importantly a tremendous benefit for the community we serve,” said Tom Scott, president and CEO of CentraState Healthcare System. “Our team has been working diligently to achieve this designation so that patients who need this higher level of cardiac care can get it right here, potentially saving lives.”

CentraState has been working toward this designation for more than a decade by educating New Jersey legislators and other stakeholders about the importance of offering this procedure to patients with heart disease. In February 2021, New Jersey Governor Murphy signed into law legislation expanding access to angioplasty procedures.

In March 2022, CentraState opened a new state-of-the-art cardiac suite with three catheterization labs in anticipation of this licensure, and quickly ramped up the number of cases required for consideration of this license. Prior to that, CentraState was licensed to perform diagnostic procedures on medically stable patients.

“The ability to offer emergency angioplasty at CentraState eliminates the need for patients and physicians to travel to another hospital for life saving care and reduce both logistical and insurance challenges that often result from that transfer,” said Chief Medical Officer James Matera, DO.

“Access to care is vital to our community and we are thankful to Senator Vin Gopal, Chairman Joseph Vitale and the Senate Health Committee for making this legislation a priority,” added Scott.


If you are a member of the media and have an inquiry or would like to schedule an interview with an executive, physician, or other clinician, please contact the Public Relations Department at 732-294-7080 during business hours. If the matter is urgent you may also call or text Lori Palmer, Director of Public Relations & Communications at 609-707-5590 or by emailing

Keep updated with the latest